// App-Quantinova.ai

2467 : The Conserved Kxgffkr Motif of ?-Integrin Cytoplasmic Tail Mediates Chemoresistance to Doxorubicin in T-Cell Leukemia.

Researchers

Presenter

  • Pascal Leclair

Principal Investigators

  • Daniel He

  • Eva Yap

  • Chinten James Lim

Medical Centers

  • Child and Family Research Institute, Vancouver, BC, Canada

  • College for Interdisciplinary Studies, University of British Columbia, Vancouver, BC, Canada

  • Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada

  • The University of British Columbia, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Annexin V

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

Drug/Treatment

  • Doxorubicin

  • Calan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved